a 2010

Intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first-line treatment in advanced non-small lung cancer (NSCLC) patients: Results of a prospective study in nonselected population

SKŘIČKOVÁ, Jana, Lenka BABIČKOVÁ, Marcela TOMÍŠKOVÁ and Bohdan KADLEC

Basic information

Original name

Intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first-line treatment in advanced non-small lung cancer (NSCLC) patients: Results of a prospective study in nonselected population

Authors

SKŘIČKOVÁ, Jana (203 Czech Republic, guarantor, belonging to the institution), Lenka BABIČKOVÁ (203 Czech Republic, belonging to the institution), Marcela TOMÍŠKOVÁ (203 Czech Republic, belonging to the institution) and Bohdan KADLEC (203 Czech Republic, belonging to the institution)

Edition

ASCO - Chicago, 2010

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30203 Respiratory systems

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/10:00046791

Organization unit

Faculty of Medicine

Keywords in English

Vinorelbine; carboplatine; NSCLC treatment
Změněno: 19/1/2011 14:04, prof. MUDr. Jana Skřičková, CSc.

Abstract

V originále

The use of intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first-line treatment in advanced non-small lung cancer (NSCLC) patients: results of a prospective study in nonselected population are reported.

Links

MSM 141100003, plan (intention)
Name: Zevní prostředí - karcinogeneze - onkologie
Investor: Ministry of Education, Youth and Sports of the CR, Environment - carcinogenesis - oncology